BlackRock Institutional Trust’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$5.23M Buy
37,092
+1,153
+3% +$163K ﹤0.01% 2707
2016
Q3
$5.25M Buy
35,939
+551
+2% +$80.4K ﹤0.01% 2668
2016
Q2
$3.56M Buy
35,388
+1,093
+3% +$110K ﹤0.01% 2814
2016
Q1
$4.59M Sell
34,295
-363
-1% -$48.6K ﹤0.01% 2700
2015
Q4
$6.89M Buy
34,658
+666
+2% +$132K ﹤0.01% 2547
2015
Q3
$5.37M Buy
33,992
+3,084
+10% +$487K ﹤0.01% 2674
2015
Q2
$12.6M Buy
30,908
+2,568
+9% +$1.05M ﹤0.01% 2248
2015
Q1
$13M Buy
28,340
+13,735
+94% +$6.31M ﹤0.01% 2223
2014
Q4
$8.2M Buy
14,605
+5,204
+55% +$2.92M ﹤0.01% 2473
2014
Q3
$4.93M Buy
9,401
+503
+6% +$264K ﹤0.01% 2690
2014
Q2
$6.21M Buy
8,898
+3,500
+65% +$2.44M ﹤0.01% 2671
2014
Q1
$2.5M Sell
5,398
-2,846
-35% -$1.32M ﹤0.01% 3068
2013
Q4
$2.83M Buy
+8,244
New +$2.83M ﹤0.01% 3021